Invention Grant
US08952051B2 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
有权
含有取代的γ-内酰胺类的眼用制剂及其使用方法
- Patent Title: Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
- Patent Title (中): 含有取代的γ-内酰胺类的眼用制剂及其使用方法
-
Application No.: US12939846Application Date: 2010-11-04
-
Publication No.: US08952051B2Publication Date: 2015-02-10
- Inventor: Anuradha V. Gore , Robert S. Jordan , Ajay Parashar , Chetan Pujara , Richard Graham , Mu-Lan Lee
- Applicant: Anuradha V. Gore , Robert S. Jordan , Ajay Parashar , Chetan Pujara , Richard Graham , Mu-Lan Lee
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Y. Bass
- Main IPC: A61K31/4025
- IPC: A61K31/4025 ; A61K9/00 ; A61K47/10 ; A61K47/26
Abstract:
The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma.
Public/Granted literature
- US20110105581A1 OPHTHALMIC FORMULATIONS CONTAINING SUBSTITUTED GAMMA LACTAMS AND METHODS FOR USE THEREOF Public/Granted day:2011-05-05
Information query
IPC分类:
